Center for Policy Analysis on Trade and Health - CPATH

TPP and Public Health 2016
Public Health on Fast Track: to House W&M 4-22-15
Support Our Work!
Campaign: Public Health Voice in Trade Policy
Malaysia Tobacco Carve Out
CPATH on Leaked TPP IP Text
Mexico, Chile on TPP-Tobacco
Tobacco & Trade Consortium 2013
2012: Health Advoacates Assert Carve-Out; U.S. Weak TPP/Tobacco Proposal
TPP Forums Jan 2012
Trans Pacific Partnership
Tobacco and Trade Publications
Trade Advisory Committees December 2010
Key Trade Agreements - CPATH Analysis and Commentary
Special 301 Hearings: Change Course!
CPATH at APHA 2009 Trade Advisory Committees
CPATH EVENT Aug. 26 2009: CAFTA and Access to Meds
Trade and Health Forum Program APHA Nov. 2009
About CPATH - Overview
CPATH Article: CAFTA Impact on Meds, Prices
Press Release: CPATH on CAFTA in Health Affairs
CAFTA aumenta los precios de medicamentos
Contact Us
Congressional Hearing on Trade Advisory Committees
Towards Change: Korea; Peru; Public Health Objectives
Trade & Health at APHA 2008
Global Trade Events at APHA November 2007
Thailand's Compulsory Licenses for Medicines
Globalization and Health Resource Center - Overview
Key Issues
CPATH Publications
Related Resources
CPATH Presentations
CPATH at US Social Forum 2007
Monterey Forum 2005
FTAA Forum
Public Health Summary Statements on Free Trade Agreements
Sign-On Statements
More About CPATH

Welcome to CPATH                       SUPPORT OUR WORK!

The Center for Policy Analysis on Trade and Health (CPATH) brings a public health voice to the debate on trade and sustainable development. We conduct research, policy analysis and advocacy in the interest of protecting and improving the health of individuals, communities and populations; expanding access to health-related services; and advancing global economic policies that are democratic, sustainable, and socially just. This website provides resources on the links between the global economy and public health priorities.

CPATH Globalization & Health Resource Center serves as a central information resource about the relationships between economic globalization, international trade agreements and economic policy, and public health. It provides timely and relevant reports from CPATH and other organizations, official texts, and links to relevant organizations and publications.

CPATH's Globalization & Health Listserv provides updates and the latest news on Trade and Health. 

Click here to sign up online for the CPATH listserv.

(Be sure to hit "Subscribe" after filling in your name and email address!  You don't need to enter a password.)

You can remove yourself from the mailing list at the same website.
Please contibute to CPATH's work using this secure online link:

The Trans Pacific Partnership is now online


CPATH: TPP Caves to the Tobacco Industry, Threatens Public Health

- Ellen R. Shaffer, Joseph E. Brenner   Nov. 5, 2015

The vacuous Trans Pacific Partnership (TPP) virtually capitulates to the demands of multinational tobacco corporations, jeopardizing nations’ health and economic welfare.  Public health and medical advocates in the U.S. and abroad consistently urged negotiators to exclude tobacco control protections from trade challenges under the TPP.  But tobacco industry opposition won the day, bolstered by corporate allies concerned that addressing the uniquely lethal effects of tobacco in trade agreements could set a precedent for reining in their own practices.

Tobacco companies increasingly turn to trade rules to delay and defeat popular initiatives to prevent or end addiction to lethal tobacco products. Trade rules grant corporations the right to directly contest and possibly overturn nations' public health and other policies.  Governments can similarly challenge each other’s tobacco control measures as trade violations. Countries that lose a trade challenge face stiff financial penalties, payable to the complaining corporation, or government.

Chapter 29 of the TPP, released today, states that any TPP nation has the right to “elect to deny” access to a trade dispute by corporations for “claims challenging a tobacco control measure”.  The country could make this election before such a challenge is submitted to arbitration, or “during the proceedings.”  If a country “elects to deny benefits with respect to such claims, any such claim shall be dismissed.”

Footnote 12 hastens to assert that governments retain the right to challenge each other’s tobacco control measures.

Footnote 13 clarifies further that a “tobacco control measure” means a “measure of a Party related to the production or consumption of manufactured tobacco products (including products made or derived from tobacco), their distribution, labeling, packaging, advertising, marketing, promotion, sale, purchase, or use, as well as enforcement measures, such as inspection, recordkeeping, and reporting requirements. [A] measure with respect to tobacco leaf that is not in the possession of a manufacturer of tobacco products or that is not part of a manufactured tobacco product is not a tobacco control measure.”

An Invitation to Political Racketeering, Declining Public Health

This "tobacco control" provision forces each TPP partner country to choose to exercise protection for tobacco control measures, instead of providing a guarantee under international law.  It subjects public health in TPP partner nations to being whipsawed by the political whims and economic agendas of powerful industries, as the political inclinations of elected administrations change.  One official speaking informally with CPATH stated that the U.S. does not “need” such an election, as the U.S. can afford to defend itself, and has “never lost such a claim.”  In fact, the U.S. lost in the case of Indonesia’s trade challenge of a ban on clove cigarettes, and has lost trade challenges at the bilateral level, such as the internet gambling dispute.  Defending against any trade dispute is costly.


It is unclear what mechanism a country would exercise to activate this provision, or what recourse would be available to state and local officials or the public in the event of an unpopular decision at the federal/national level not to exercise the “election to deny” a tobacco-related trade challenge. 

In addition, by requiring each country to take unilateral action to elect to deny the use of the TPP’s trade dispute mechanism, it leaves that country subject to charges that it is violating other agreements that include an investor-state dispute systems (ISDS), or violating WTO agreements. In fact, Australia currently faces trade charges at both the ISDS and WTO levels, due to anti-smoking graphics and health warnings on cigarette packages. Some officials and advocates have expressed caution about acknowledging that any of its tobacco control measures are in any way not compliant with trade rules.

This provision is an ongoing open invitation to the global tobacco industry to sharpen its arrows to ensure that no country executes this option to safeguard public health and protect tobacco control measures.  The TPP invites political racketeering and pernicious lobbying at every level of government to protect the prerogatives of the tobacco industry, in alliance with any and every other commercial enterprise that might conflict with public health protections.

The alternative is to build on the international consensus that population health is paramount, and to set an international health standard as a first step, making it a violation of international law to pursue a trade challenge in the case of tobacco control measures.

Tobacco use costs the U.S. far more in lives and health care expenses than tobacco farming or manufacturing contribute to the economy. 

·       Tobacco use kills 1,200 Americans daily.  Cigarette smoking is responsible for an estimated $193 billion in annual health-related economic losses in the U.S. (nearly $96 billion in direct medical costs and an additional $97 billion in lost productivity).

·       In contrast, total tobacco exports generate 0.10 percent (one tenth of one percent) of total U.S. annual exports (.07% unmanufactured, and .03% manufactured). Tobacco manufacturing has declined exponentially in the U.S., and tobacco farming is also in decline, due in part to U.S. programs intended to facilitate the transition to more sustainable crops.

·       Exports of cigarettes and other U.S.-manufactured tobacco products dropped from $3.9 billion in 1999 to $488 million in 2011, as large U.S. manufacturers sold off their international businesses or formed subsidiaries located abroad. Ninety-eight percent of exported U.S. cigarettes go to 5 countries, only one of which is a TPP partner (Japan).   Lower tariffs would lower the price of tobacco products, resulting in cheaper prices and increased consumption and use, especially among younger people. For this reason, international health policy and U.S. law prohibit the U.S. from using trade agreements to promote the sale or export of tobacco products. Yet the U.S. proposes in the TPP to eliminate tariffs on tobacco products.  Other TPP partners can reasonably object to encouraging the import of U.S. brand cigarettes. 

Tobacco is the only legal consumer product that kills when used as intended. Tobacco use is the leading preventable cause of death worldwide, accounting for 6 million preventable deaths annually, and is a major contributor to the global pandemic of non-communicable diseases, including childhood morbidity and mortality.  As a unique product, it must be treated differently from other products and services that are traded across borders.


APHA leaders support CPATH Call for Trade Accountability

Bringing a Public Health Voice to Global Trade and Sustainable Development
Ellen R. Shaffer and Joe Brenner, Co-Directors
San Francisco Presidio
P.O. Box 29586, San Francisco, CA 94129
phone 415-922-6204